The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD and Safety
Clinical trial NCT04778137 · COMPLETED
Trial details
- NCT number
- NCT04778137
- Sponsor
- Taizhou Mabtech Pharmaceutical Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-04-26
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.